HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,870 | -24.0% | 860,474 | -28.2% | 0.04% | -15.1% |
| Q2 2023 | $43,235 | +61.8% | 1,198,667 | +71.3% | 0.05% | +51.4% |
| Q1 2023 | $26,717 | +5.4% | 699,604 | +57.0% | 0.04% | 0.0% |
| Q4 2022 | $25,351 | -99.9% | 445,541 | -8.6% | 0.04% | +25.0% |
| Q3 2022 | $19,273,000 | +7200.4% | 487,443 | +8020.0% | 0.03% | – |
| Q2 2022 | $264,000 | +3671.4% | 6,003 | +3010.4% | 0.00% | – |
| Q1 2022 | $7,000 | -94.5% | 193 | -93.9% | 0.00% | – |
| Q4 2021 | $127,000 | +23.3% | 3,177 | +25.2% | 0.00% | – |
| Q3 2021 | $103,000 | -15.6% | 2,538 | -6.0% | 0.00% | – |
| Q2 2021 | $122,000 | +17.3% | 2,700 | +7.9% | 0.00% | – |
| Q1 2021 | $104,000 | +20.9% | 2,502 | +23.7% | 0.00% | – |
| Q4 2020 | $86,000 | +62.3% | 2,022 | 0.0% | 0.00% | – |
| Q3 2020 | $53,000 | -98.7% | 2,022 | -98.7% | 0.00% | -100.0% |
| Q2 2020 | $4,041,000 | +9084.1% | 150,740 | +5877.0% | 0.01% | – |
| Q4 2019 | $44,000 | +528.6% | 2,522 | +443.5% | 0.00% | – |
| Q3 2019 | $7,000 | – | 464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |